CD22 Antikörper
Kurzübersicht für CD22 Antikörper (ABIN400636)
Target
Alle CD22 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Produktmerkmale
- Synonyms: SIGLEC2, Siglec-2, B-cell receptor CD22, Leu-14, BL-CAM, Sialic acid-binding Ig-like lectin 2,B-lymphocyte cell adhesion molecule
-
Aufreinigung
- Protein A affinity chromatography
-
Reinheit
- > 95 % by SDS-PAGE
-
Immunogen
- Reh human cell line
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Flow Cytometry. Positive control: lysed whole blood.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Azide free phosphate buffered saline (PBS), approx. pH 7.4, 0.2 μm filter sterilized.
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
-
Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C. Avoid repeated freezing andthawing.
Shelf life: one year from despatch. -
Haltbarkeit
- 12 months
-
-
- CD22 (CD22 Molecule (CD22))
-
Andere Bezeichnung
- CD22
-
Hintergrund
- CD22, also known as Siglec-2 (sialic acid-binding immunoglobulin-like lectin-2) is a transmembrane glycoprotein binding alpha2,6-linked sialic acid-bearing ligands. Intracellular domain of CD22 recruits protein tyrosine phosphatase SHP-1 through the immunoreceptor tyrosine-based inhibitory motifs (ITIMs), thus setting a treshold for B cell receptor-mediated activation. CD22 also regulates B-cell response by involvement in controlling the CD19/CD21-Src-family protein tyrosine kinase amplification pathway and CD40 signaling. CD22 exhibits hallmarks of clathrin-mediated endocytic pathway.Synonyms: B-cell receptor CD22, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14, SIGLEC2, Sialic acid-binding Ig-like lectin 2, Siglec-2
-
UniProt
- P20273
Target
-